F7 and interstitial lung disease: A few small clinical studies have reported on the safety of dabigatran use in patients with ILD.30,31 Warfarin can also be a factor in decreased inflammation and thrombin generation by reducing plasma factor VII, an important thrombin precursor in the coagulation cascade.